Furthermore, the high concordance rate found between serum VISTA levels and VISTA-positive cancer cells in the FMC cases suggests VISTA protein as a non-invasive diagnostic biomarker, as reported for breast cancer patients [42,68]. The gene discussed is VSIR; the disease is cancer.